Return to Trial Database

HCRN-GU16-287

Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer

Status

Enrollment Closed

Cancer Type(s)

Bladder Urothelial Carcinoma

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-GU16-287 being conducted in.

Huntsman Cancer Institute at the University of Utah

Icahn School of Medicine at Mount Sinai

Rutgers Cancer Institute of New Jersey

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Vanderbilt-Ingram Cancer Center